{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:15:47Z","timestamp":1791494147973,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["C26H15Y42B"],"award-info":[{"award-number":["C26H15Y42B"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ebiom.2020.103098","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T16:53:58Z","timestamp":1604681638000},"page":"103098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5970-9693","authenticated-orcid":false,"given":"Alessio","family":"Ugolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria Grazia","family":"Zizzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Botticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Colasanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Strigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Rughetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.103098_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.103098_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2016.01.017","article-title":"Autoantibody production in cancer-the humoral immune response toward autologous antigens in cancer patients","author":"Zaenker","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ebiom.2020.103098_bib0003","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/ard.51.9.1029","article-title":"Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study","volume":"51","author":"Van Zeben","year":"1992","journal-title":"Ann Ofthe Rheum Dis Rheum Dis"},{"key":"10.1016\/j.ebiom.2020.103098_bib0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/oso\/9780198566304.003.0013","article-title":"Autoantibodies in rheumatoid arthritis: prevalence and clinical significance","author":"Steiner","year":"2006","journal-title":"Rheum. Arthritis"},{"key":"10.1016\/j.ebiom.2020.103098_bib0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","article-title":"Rheumatoid factor revisited","volume":"16","author":"D\u00f6rner","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.ebiom.2020.103098_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ije\/1.3.211","article-title":"Rheumatoid factor in Iceland: a population study","volume":"1","author":"Allander","year":"1972","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0008","first-page":"183","article-title":"A population study of rheumatoid factor in Iceland. A 5-year follow-up of 50 women with rheumatoid factor (RF)","volume":"7","author":"Thorsteinsson","year":"1975","journal-title":"Ann Clin Res"},{"key":"10.1016\/j.ebiom.2020.103098_bib0009","first-page":"75","article-title":"Factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts","author":"Ajeganova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ebiom.2020.103098_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-017-3738-x","article-title":"Rheumatoid factor positivity increases all-cause and cancer mortality: a cohort study","author":"Ahn","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ebiom.2020.103098_bib0011","first-page":"121","article-title":"Rheumatoid factor: correlation with recurrence in transitional cell carcinoma of the bladder","author":"Gupta","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0012","first-page":"52","article-title":"Rheumatoid factors in the sera of patients with gastrointestinal carcinoma","author":"Schattner","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ebiom.2020.103098_bib0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1078-0432.CCR-13-2573","article-title":"CD137 as a biomarker for tumor-reactive T cells: finding gold in the desert","volume":"20","author":"Zhu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2020.103098_bib0014","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-13-0945","article-title":"CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor","author":"Ye","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2020.103098_bib0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-1847-x","article-title":"A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab","author":"Botticelli","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.ebiom.2020.103098_bib0016","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","article-title":"Rheumatoid factors: clinical applications","volume":"35","author":"Ingegnoli","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.ebiom.2020.103098_bib0017","first-page":"403","article-title":"Immunological responses of a healthy elderly population","volume":"48","author":"Goodwin","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0018","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/rheumatology\/32.2.104","article-title":"Rheumatoid arthritis in a population of persons aged 85 years and over","volume":"32","author":"Van Schaardenburg","year":"1993","journal-title":"Rheumatology"},{"key":"10.1016\/j.ebiom.2020.103098_bib0019","first-page":"11","article-title":"Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems","author":"Ursum","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ebiom.2020.103098_bib0020","first-page":"15","article-title":"A rheumatoid factor paradox: inhibition of rituximab effector function","author":"Jones","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ebiom.2020.103098_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2019.04.006","article-title":"Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome","author":"Colucci","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ebiom.2020.103098_bib0022","article-title":"Sialylation of N-Linked Glycans Influences the Immunomodulatory Effects of IgM on T Cells","author":"Colucci","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.02.024","article-title":"Fc\u03bc receptor as a Costimulatory Molecule for T Cells","author":"Meryk","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2020.103098_bib0024","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20091107","article-title":"Identity of the elusive IgM Fc receptor (Fc\u03bcR) in humans","author":"Kubagawa","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2020.103098_bib0025","article-title":"Role of the IgM Fc receptor in immunity and tolerance","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0026","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1200840","article-title":"Toso, a functional IgM receptor, Is Regulated by IL-2 in T and NK Cells","author":"Murakami","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/clim.2002.5210","article-title":"Rheumatoid factors: host resistance or autoimmunity?","volume":"104","author":"Newkirk","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0028","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/rheumatology\/kei228","article-title":"Rheumatoid factors: what's new?","volume":"45","author":"Westwood","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.ebiom.2020.103098_bib0029","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-17-0594","article-title":"TK inhibitor pazopanib primes DCs by downregulation of the \u03b2-catenin pathway","author":"Zizzari","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ebiom.2020.103098_bib0030","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminoncol.2017.06.007","article-title":"Nivolumab and pembrolizumab: monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable","author":"Prasad","year":"2017","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051340","article-title":"Mechanisms of Intrinsic Tumor Resistance to Immunotherapy","author":"Rieth","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2020.103098_bib0032","article-title":"Is Nivolumab safe and effective in elderly and PS2 patients with non-small cell lung cancer (NSCLC)? results of checkmate 153","author":"D. S, L. S, D. W, J. C, M. H, R. J","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2020.103098_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2017.11.015","article-title":"Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: the real-life data","author":"Dudnik","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ebiom.2020.103098_bib0034","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.jbchem.a022794","article-title":"Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation","author":"Matsumoto","year":"2000","journal-title":"J Biochem"},{"key":"10.1016\/j.ebiom.2020.103098_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01483","article-title":"How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis","author":"Steffen","year":"2019","journal-title":"Front Immunol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420304746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420304746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:38Z","timestamp":1778873558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420304746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"alternative-id":["S2352396420304746"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103098","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103098"}}